The American Society of Clinical Oncology (ASCO) sponsors a session at the 6th Southeast Asia Breast Cancer Symposium (SEABCS) to be held online from September 23-25, 2022.

On the first day of the conference, ASCO panelists will discuss, “Doing What’s Best for your Patients: Putting the Latest Findings from the 2022 ASCO Annual Meeting into Practice in LMIC (low to middle-income countries) Settings”.

Dr. Roselle de Guzman, a Philippines-based medical oncologist, academic and chair of ASCO’s Asia Pacific Regional Council, says, “We are excited to welcome the experts from the American Society of Clinical Oncology. They will share and discuss the latest research findings in breast cancer treatment. We hope to have an interactive discussion and know more about how the information can be applied to improve the care of our patients in Southeast Asia. Breast cancer knows no boundaries.  Access to the best and most appropriate treatment and care despite the limitation in resources is crucial for every patient with breast cancer in this part of the world.”

Speaking at this particular ASCO session are medical doctors Julie Gralow, Don Dizon, Mylin Torres and Jane Brock.

Gralow is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN), and supports patient advocates in low- and middle-resource countries. She is currently chief medical officer and executive vice president of ASCO. She is also a professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center and director of Breast Medical Oncology at the Seattle Cancer Care Alliance.

Dizon is a medical oncologist specializing in the care of women with breast or gynecologic cancers, survivorship particularly as it pertains to sexual health for men and women with cancer, patient engagement, and social media. He is an ASCO fellow and chairs the Digital Engagement for SWOG Oncology Research Network.

Torres is a professor in the Department of Radiation Oncology at Emory University School of Medicine in Atlanta, Georgia. She serves as co-leader of the Cancer Prevention and Control research program at Winship Cancer Institute of Emory University where she coordinates and promotes all of the cancer prevention and control-related research activities. She practices general radiation oncology and specializes in the treatment of breast cancer.

Brock is the chief of the Breast Pathology Division, Brigham and Women’s Hospital, the second largest teaching hospital of Harvard Medical School in Boston, Massachusetts. She is the hospital’s Breast Pathology Fellowship program director and also medical director of the Surgical Pathology Grossing Room. She is an associate professor of Pathology at Harvard Medical School.

On the second day of SEABCS, Brock and Gralow will lead a track on “The power of the measured Marker,” referring to tumor markers or substances that are found in higher-than-normal levels in the blood or tissue of some people with cancer. Also on the second day, Gralow will join a panel on “Making Personalized Medicine the Standard in Breast Care.”

On the third day, Dizon will be part of a panel on “Post-treatment Breast Health” which will cover follow up care and other survivorship issues.

Philippines-based ICANSERVE Foundation, Inc. and U.S.-based Global Focus on Cancer host this year’s SEABCS previously held in Vietnam (2016), Myanmar (2017), Malaysia (2018), Thailand (2019), and Indonesia (2021- virtual conference).

Join the conversation. Registration is free. Register for the virtual conference at

Spread the love